Anti-CD226 antibody [BLR063G] - BSA free (ab264415)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [BLR063G] to CD226 - BSA free
- Suitable for: IP, WB, IHC-P, ICC
- Reacts with: Human
Overview
-
Product name
Anti-CD226 antibody [BLR063G] - BSA free
See all CD226 primary antibodies -
Description
Rabbit monoclonal [BLR063G] to CD226 - BSA free -
Host species
Rabbit -
Tested Applications & Species
See all applications and species dataApplication Species ICC HumanIHC-P HumanWB Human -
Immunogen
Recombinant fragment within Human CD226 aa 19-229 (extracellular). The exact sequence is proprietary. NP_006557.2.
Database link: Q15762 -
Positive control
- IHC-P: Human lung carcinoma tissue. ICC: Jurkat and HH cells. WB: SUP-M2, HH and Jurkat whole cell lysates. IP: HH cell lysate.
-
General notes
This product is sold under License from Bethyl Laboratories, Inc
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.8
Preservative: 0.09% Sodium azide
Constituent: 99% Borate buffered saline -
Concentration information loading...
-
Purification notes
Purified from cell culture supernatant. -
Clonality
Monoclonal -
Clone number
BLR063G -
Isotype
IgG -
Research areas
Images
-
Formalin-fixed, paraffin embedded human lung carcinoma tissue stained for CD226 using ab264415 at 1/200 dilution in immunohistochemical analysis. Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.
-
Formalin-fixed, paraffin-embedded Jurkat (human T cell leukemia cell line from peripheral blood) cells stained for CDD226 using ab264415 at 1/200 dilution in imunocytochemical analysis. Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.
-
All lanes : Anti-CD226 antibody [BLR063G] - BSA free (ab264415) at 1/1000 dilution
Lane 1 : RT4 (human urinary bladder cancer cell line) whole cell lysate
Lane 2 : SUP-M2 whole cell lysate
Lane 3 : U-251 MG (human brain glioma cell line) whole cell lysate
Lane 4 : HH whole cell lysate
Lane 5 : MJ whole cell lysate
Lane 6 : Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate
Lane 7 : HDLM-2 whole cell lysate
Lane 8 : HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate
Lysates/proteins at 50 µg per lane.
Secondary
All lanes : HRP-conjugated goat anti-rabbit IgG
Developed using the ECL technique.
Predicted band size: 39 kDa
Exposure time: 3 secondsLysates prepared using NETN lysis buffer.
-
CD226 was immunoprecipitated from HH whole cell lysate (1.0 mg per IP reaction; 20% of IP loaded) using ab264415 at 6 µl per reaction. Western blot was performed on the immunoprecipitates using ab264415 at 1/1000 dilution.
Lane 1: ab264415 IP in HH cell lysate.
Lane 2: Control IgG IP in HH cell lysate.
Detection: Chemiluminescence with an exposure time of 3 seconds.
Lysates prepared using NETN lysis buffer.
-
Formalin-fixed, paraffin-embedded HH cells stained for CDD226 using ab264415 at 1/200 dilution in imunocytochemical analysis. Secondary: HRP-conjugated goat anti-rabbit IgG. Substrate: DAB.
-